DelveInsight's 'Follicular Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and ...

Reid Merryman, MD, discusses which patients are typically monitored for minimal residual disease and whether there are ...

Our bodies divest themselves of 60 billion cells every day through a natural process of cell culling and turnover called ...

“No risks of concern to human health from current uses of glyphosate. Glyphosate products used according to label directions ...

Antengene Corporation Limited (HK:6996) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; ...

Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) made a significant decision to dismiss Ernst & Young LLP (EY) as its independent registered public accounting firm. The Delaware corporation, on November 21, ...

中国上海和香港，2024年11月28日–致力于研发，生产和销售同类首款及/或同类最优血液及实体肿瘤疗法的商业化阶段领先创新生物制药公司–德琪医药有限公司（简称“德琪医药”，香港交易所股票代码：6996.HK）今日宣布，希维奥（塞利尼索片）新增一项适应 ...